About immunitoAI
immunitoAI is a company based in Bengaluru (India) founded in 2020 by Trisha Chatterjee and Aridni Shah.. immunitoAI has raised $7.95 million across 5 funding rounds from investors including LetsVenture, Apex Group and Anicut Capital. The company has 17 employees as of April 08, 2024. immunitoAI offers products and services including AI Platform. immunitoAI operates in a competitive market with competitors including AbSci, LabGenius, Ordaos, Enpicom and Alkira Bio, among others.
- Headquarter Bengaluru, India
- Employees 17 as on 08 Apr, 2024
- Founders Trisha Chatterjee, Aridni Shah
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Immunitoai Private Limited
- Date of Incorporation 28 Nov, 2020
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$8.19 K (USD)209.88as on Mar 31, 2023
-
Net Profit
$-350.25 K (USD)-51.51as on Mar 31, 2023
-
EBITDA
$-335.74 K (USD)-47.31as on Mar 31, 2023
-
Total Equity Funding
$7.95 M (USD)
in 5 rounds
-
Latest Funding Round
$6.1 M (USD), Series A
Nov 25, 2025
-
Investors
LetsVenture
& 21 more
-
Employee Count
17
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of immunitoAI
immunitoAI offers a comprehensive portfolio of products and services, including AI Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Generates novel antibodies using AI for therapeutic development.
Unlock access to complete
Funding Insights of immunitoAI
immunitoAI has successfully raised a total of $7.95M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $6.1 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $6.1M
-
First Round
First Round
(05 Mar 2021)
- Investors Count 22
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series A - immunitoAI | Valuation |
investors |
|
| Aug, 2025 | Amount | Seed - immunitoAI | Valuation | C-CAMP |
|
| Jan, 2025 | Amount | Seed - immunitoAI | Valuation | Aneesh Venkatadri |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in immunitoAI
immunitoAI has secured backing from 22 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include LetsVenture, Apex Group and Anicut Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services in private credit, seed funds, growth equity, and late-stage equity for businesses in India.
|
Founded Year | Domain | Location | |
|
Deep-tech venture capital investments in early-stage companies.
|
Founded Year | Domain | Location | |
|
Early-stage technology companies are invested in by Jj Family Office.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by immunitoAI
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - immunitoAI
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immunitoai Comparisons
Competitors of immunitoAI
immunitoAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AbSci, LabGenius, Ordaos, Enpicom and Alkira Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| domain | founded_year | HQ Location |
AI-driven platform for discovering and optimizing therapeutic antibodies for treatments.
|
|
| domain | founded_year | HQ Location |
AI accelerator provided for biomedical research and drug discovery.
|
|
| domain | founded_year | HQ Location |
Developer of bioinformatics platform integrating data, automation, and AI for biologics
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies targeting complex membrane proteins are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about immunitoAI
When was immunitoAI founded?
immunitoAI was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is immunitoAI located?
immunitoAI is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Who is the current CEO of immunitoAI?
Aridni Shah is the current CEO of immunitoAI. They have also founded this company.
Is immunitoAI a funded company?
immunitoAI is a funded company, having raised a total of $7.95M across 5 funding rounds to date. The company's 1st funding round was a Seed of $341.07K, raised on Mar 05, 2021.
How many employees does immunitoAI have?
As of Apr 08, 2024, the latest employee count at immunitoAI is 17.
What is the annual revenue of immunitoAI?
Annual revenue of immunitoAI is $8.19K as on Mar 31, 2023.
What does immunitoAI do?
immunitoAI was founded in 2020 in Bengaluru, India, within the biotechnology sector. An AI-driven platform is provided by the company for antibody discovery and therapeutic development. Antibody sequences are screened and ranked through imRANK to predict binding strength with antigens. Regions of antibodies are identified and mutated via imEVOLVE to enhance affinity. Operations are centered on computational tools for pharmaceutical applications in the region.
Who are the top competitors of immunitoAI?
What products or services does immunitoAI offer?
immunitoAI offers AI Platform.
Who are immunitoAI's investors?
immunitoAI has 22 investors. Key investors include LetsVenture, Apex Group, Anicut Capital, pi Ventures, and Jj Family Office.
What is immunitoAI's valuation?
The valuation of immunitoAI is $4.34M as of Feb 2024.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.